Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Pocock

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Brain : a Journal of Neurology|October 7, 2021
A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 geneNaciye Magusali, Andrew C Graham, Thomas M Piers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
First-in-Class SAM-Competitive G9a Inhibitor FLAV-27 as a Disease-Modifying Therapy for Alzheimer's DiseaseAina Bellver-Sanchis, David Valle-Garcia, Carla Barbaraci, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Brain : a Journal of Neurology|October 7, 2021
A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 geneNaciye Magusali, Andrew C Graham, Thomas M Piers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
First-in-Class SAM-Competitive G9a Inhibitor FLAV-27 as a Disease-Modifying Therapy for Alzheimer's DiseaseAina Bellver-Sanchis, David Valle-Garcia, Carla Barbaraci, et al.
Pageof 5